Inventor
MCGUINNESS BRIAN F
US23 patents
⚠️ This page may combine multiple inventors who share the name “MCGUINNESS BRIAN F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
11 patentsUS7566718B2Jul 28, 2009
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP73 citations97
US7417045B2Aug 26, 2008
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
SCHERING CORP64 citations97
US7799789B2Sep 21, 2010
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
SCHERING CORP10 citations84
US7763616B2Jul 27, 2010
Piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP10 citations84
US7868005B2Jan 11, 2011
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP9 citations83
US7879838B2Feb 1, 2011
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP10 citations82
US7776862B2Aug 17, 2010
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP12 citations81
US7786124B2Aug 31, 2010
Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity
SCHERING CORP6 citations74
US8017616B2Sep 13, 2011
Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity
SCHERING CORP3 citations63
US7902199B2Mar 8, 2011
Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity
SCHERING CORP2 citations63
US7868006B2Jan 11, 2011
Heterocyclic substituted piperazines with CXCR3 antagonist activity
SCHERING CORP3 citations62
LIGAND PHARM INC
6 patentsUS10030034B2Jul 24, 2018
Heterocycle amines and uses thereof
LIGAND PHARM INC5 citations82
US11186593B2Nov 30, 2021
Heterocycle amines and uses thereof
LIGAND PHARM INC1 citations71
US10604533B2Mar 31, 2020
Heterocycle amines and uses thereof
LIGAND PHARM INC1 citations71
US11773110B2Oct 3, 2023
Heterocycle amines and uses thereof
LIGAND PHARM INC0 citations61
US9266874B2Feb 23, 2016
Heterocycle amines and uses thereof
LIGAND PHARM INC2 citations61
US8822467B2Sep 2, 2014
Biaryl oxyacetic acid compounds
LIGAND PHARM INC0 citations40
VENENUM BIODESIGN LLC
5 patentsUS10654834B2May 19, 2020
Non-systemic TGR5 agonists
VENENUM BIODESIGN LLC3 citations68
US11883420B2Jan 30, 2024
Sting agonists for treating bladder cancer and solid tumors
VENENUM BIODESIGN LLC0 citations55
US11110106B2Sep 7, 2021
Sting agonists for treating bladder cancer and solid tumors
VENENUM BIODESIGN LLC0 citations54
US11236055B2Feb 1, 2022
Non-systemic TGR5 agonists
VENENUM BIODESIGN LLC0 citations47
US11161864B2Nov 2, 2021
Sting agonists
VENENUM BIODESIGN LLC0 citations44